Search

Your search keyword '"Isonicotinic Acids therapeutic use"' showing total 128 results

Search Constraints

Start Over You searched for: Descriptor "Isonicotinic Acids therapeutic use" Remove constraint Descriptor: "Isonicotinic Acids therapeutic use"
128 results on '"Isonicotinic Acids therapeutic use"'

Search Results

1. The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease.

2. Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer.

3. Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases.

4. Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial.

5. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.

6. Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models.

7. Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.

8. Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.

9. Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.

10. Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs).

11. [Present and future in the use of anti-tubercular drugs].

12. Current development and future prospects in chemotherapy of tuberculosis.

13. LL-3858.

14. GABA(A) receptor ligands and their therapeutic potentials.

15. [The neurotropic and cardiotropic properties of new amino acid derivatives of isonicotinic acid].

16. Tuberculous brain infection located in an old cerebral infarct: CT changes with successful conservative therapy.

17. [Long-term treatment of tuberculosis with isoprodian (author's transl)].

18. Tolerability and efficacy of isoprodian-containing antituberculosis regimens.

19. [Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].

20. [The current state of cutaneous tuberculosis].

21. [Determination of the anti-anoxia capacity of drugs].

22. [Chemoprevention and preventive chemotherapy of tuberculosis in adulthood (Review)].

25. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].

26. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].

27. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.

28. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.

29. Deep vein thrombosis in surgery. Detection by the method using labelled fibrinogen.

31. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.

32. [Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal].

34. [Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].

35. The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosis.

37. [Modern therapy and after-care in urogenital tuberculosis].

38. GABA receptor agonists: pharmacological spectrum and therapeutic actions.

39. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.

41. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.

42. [Use of pyridoxylate for treating chronic coronary insufficiency].

44. [Therapeutic effectiveness of pyridoxine pyrrolidonecarboxylate in febrile convulsions in children].

45. [New drugs in the treatment of leprosy].

46. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.

48. [Incidence and treatment of oral lichen planus].

49. Prothionamide and prothionamide-S-oxide in experimental leprosy.

50. [A new therapeutic approach to open pulmonary tuberculosis with a combination of isoniazid, prothionamid and dapson (author's transl)].

Catalog

Books, media, physical & digital resources